| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.34 | 0.03 |